Growth Metrics

Enanta Pharmaceuticals (ENTA) Property, Plant & Equipment (Net) Growth (3y) (2015 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Net) Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -14.40%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 3.41%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -9.89%
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 13.10%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 10.71%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -0.31%
10 Enanta Pharmaceuticals 367.22 Mn 203.44 Mn - 44.17%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 44.17%
Dec 31, 2025 58.10%
Sep 30, 2025 78.98%
Jun 30, 2025 99.84%
Mar 31, 2025 98.35%
Dec 31, 2024 90.15%
Sep 30, 2024 76.52%
Jun 30, 2024 55.89%
Mar 31, 2024 30.05%
Dec 31, 2023 15.88%
Sep 30, 2023 11.51%
Jun 30, 2023 8.97%
Mar 31, 2023 4.30%
Dec 31, 2022 -5.86%
Sep 30, 2022 -17.33%
Jun 30, 2022 -26.11%
Mar 31, 2022 -25.14%
Dec 31, 2021 -16.96%
Sep 30, 2021 -10.80%
Jun 30, 2021 -7.60%
Mar 31, 2021 -6.52%
Dec 31, 2020 -0.35%
Sep 30, 2020 2.22%
Jun 30, 2020 4.79%
Mar 31, 2020 4.53%
Dec 31, 2019 7.81%
Sep 30, 2019 10.93%
Jun 30, 2019 14.89%
Mar 31, 2019 14.27%
Dec 31, 2018 6.44%
Sep 30, 2018 12.47%
Jun 30, 2018 48.07%
Mar 31, 2018 55.42%
Dec 31, 2017 59.98%
Sep 30, 2017 64.66%
Jun 30, 2017 73.28%
Mar 31, 2017 83.63%
Dec 31, 2016 97.57%
Sep 30, 2016 92.56%
Jun 30, 2016 86.72%
Mar 31, 2016 106.30%
Sep 30, 2015 112.78%